NEW YORK, March 14 (GenomeWeb News) - Oxford Biomedical Research and Qualyst have inked a deal to create a product line of cytochrome P450-inhibition assays to be sold as Accuratet, the companies said today.
Registering provides access to this and other free content.
Already have an account?Login Now.
An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.
Research funding in Canada is to remain mostly the same, ScienceInsider reports.
In Science this week: random DNA replication errors play role in cancer, and more.
The Bill and Melinda Gates Foundation embarks on an open-access publishing path.